Novartis Agrees to Buy Chinook for Up to $3.5 Billion

Novartis’s Sandoz Sees Pipeline Adding $3 Billion Sales by 2028

Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data

Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut